The 2022 report on findings of the unlinked anonymous monitoring survey of HIV and viral hepatitis among people who inject drugs contains updates on hepatitis C prevalence, testing uptake and care & treatment.
Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement
Download
This paper reports on the results of a 2011 EASL meeting and subsequent dialogue with patient groups and relevant experts in Europe. It summarises the current knowledge of HCV infection and the brain; prevalence, course, and neurobiology of IFN-a associated psychiatric side effects; possible risk factors for IFN-a associated depression and suicide attempts; psychiatric management of HCV infected patients before and during antiviral treatment; prevention of IFN- a associated psychiatric side effects; and psychiatric aspects of the new antivirals.
